WAMU 88.5 - American University Radio | The Mind Is Our Medium
Now Playing

Johnson & Johnson Settles Marketing Charges

Johnson & Johnson became the latest drugmaker to reach a costly agreement with the federal government over charges of improper marketing. The widely anticipated settlement, unveiled Monday, covers Natrecor, a drug for congestive heart failure, and antipsychotics Risperdal and Invega.